“Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase”. Canadian Dermatology Today 7, no. 3 (September 25, 2026): 4–10. Accessed September 28, 2026. https://canadiandermatologytoday.com/article/view/7-3-Netchiporouk_et_al.